FDA Approves Device to Treat Severe Chronic Heart Failure

FDA Approves Device to Treat Severe Chronic Heart Failure »

22 Mar, 2019
News
  The U.S. Food and Drug Administration (FDA) has approved Impulse Dynamics’ Optimizer Smart system for delivering cardiac contractility modulation therapy for patients with chronic, moderate-to-severe heart failure who are not suited for treatment with other heart failure devices. The Optimizer Smart system was granted breakthrough device designation in 2015 because it treats heart failure —…

Send this to a friend